Genetic Testing Market Outlook 2026–2030 Exploring New Business Opportunities
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Genetic Testing Market Over The Period 2026–2030?
The genetic testing market has experienced robust growth recently. It is projected to expand from $20.84 billion in 2025 to $22.91 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. This historical growth can be attributed to advancements in molecular biology, declining DNA sequencing costs, increased awareness of genetic disorders, the expansion of diagnostic laboratories, and its early adoption in oncology.
The genetic testing market is anticipated to show significant expansion in the coming years, with its valuation expected to reach $32.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This projected growth throughout the forecast period stems from factors such as the advancement of personalized medicine, the integration of genetic data into clinical decisions, the rising incidence of chronic diseases, the expansion of preventive healthcare initiatives, and improvements in genetic counseling services. Key trends identified for this period include a greater adoption of predictive genetic testing, the increased application of prenatal and newborn screening, growing demand for pharmacogenomics testing, the broadening scope of cancer genetic diagnostics, and enhanced availability of direct-to-consumer genetic tests.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6729&type=smp
Which Economic Or Industry Drivers Are Impacting The Genetic Testing Market?
The increasing occurrence of genetic conditions is anticipated to fuel the expansion of the genetic testing market in the future. Genetic disorders are illnesses that can manifest symptoms at birth or emerge later in life. Genetic testing offers assistance in diagnosing such conditions and provides insights into cancer development risks. For example, a 2024 report by the World Health Organization, an Intergovernmental organization based in Switzerland, indicated that genetic disorders and congenital abnormalities impact 2%-5% of live births, contribute to 30% of pediatric hospital admissions, and are responsible for approximately 50% of childhood deaths in industrialized nations. Consequently, the growing prevalence of genetic disorders is a key driver for the genetic testing market.
How Is The Genetic Testing Market Divided Into Its Major Segments?
The genetic testing market covered in this report is segmented –
1) By Type: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing, Other Types
2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing
3) By Application: Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications
4) By End User: Hospitals And Clinics, Diagnostic Laboratories And Centres, Other End Users
Subsegments:
1) By Predictive Testing: Genetic Risk Assessment, Family History-Based Testing
2) By Carrier Testing: Single Gene Carrier Testing, Expanded Carrier Screening
3) By Prenatal And Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Newborn Screening Tests
4) By Diagnostic Testing: Confirmatory Genetic Testing, Clinical Diagnostic Testing
5) By Pharmacogenomics Testing: Drug Response Testing, Adverse Drug Reaction Testing
6) By Nutrigenomic Testing: Dietary Response Testing, Metabolism Testing
7) By Other Types: Ancestry Testing, Whole Genome Sequencing
What Key Trends Are Influencing The Development Of The Genetic Testing Market?
Leading companies active in the genetic testing market are concentrating on developing advanced solutions, including AI-driven genomic interpretation algorithms, to satisfy the growing demand for better variant classification, improved diagnostic accuracy, and increased diversity in precision healthcare. AI-based genomic interpretation tools examine large genetic datasets to identify pathogenic variants with greater efficiency than traditional manual or rule-based methods, providing quicker insights, reduced uncertainty, and higher predictive accuracy in genetic testing. For example, in June 2023, Illumina, Inc., a U.S.-based biotechnology and medical equipment company, revealed PrimateAI-3D, a groundbreaking artificial intelligence algorithm created to predict disease-causing genetic mutations. This tool utilizes a 3D structural understanding of proteins and evolutionary comparisons across primate species to prioritize potentially pathogenic variants. It enhances large-scale genomic interpretation, accelerates precision medicine, and improves diagnostic workflows by allowing researchers and clinicians to more precisely assess genetic risk. PrimateAI-3D supports faster, more reliable detection of clinically relevant mutations, ultimately strengthening genetic testing capacities.
Who Are The Prominent Organizations Shaping The Genetic Testing Market?
Major companies operating in the genetic testing market are Myriad Genetics Inc, Illumina Inc, Abbott Laboratories, Eurofins Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Qiagen NV, Thermo Fisher Scientific Inc., BioRad Laboratories Inc., BGI, Berry Genomics Co. Ltd, Daan Gene Co. Ltd, Annoroad Gene Technology Co. Ltd, Igenomix, Circle DNA, Centogene, Probably Genetic, Genome Biologics, WuXi NextCODE, Genomtec, Testgene, Evogen Lab, Phosphorus, Helix, 10x Genomics, Quantgene, DNALabs, Deep Genomics, Hologic Inc, Molecular Biology & Genetics Laboratory, IVI MIDDLE EAST FERTILITY CLINIC, Bio Certica
Read the full genetic testing market report here:
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
What Are The Top-Performing Regions Within The Genetic Testing Market?
North America was the largest region in the genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Genetic Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=6729&type=smp
Browse Through More Reports Similar to the Global Genetic Testing Market 2026, By The Business Research Company
Epigenetics Global Market Report
https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report
Genetically Modified Fruits Global Market Report
https://www.thebusinessresearchcompany.com/report/genetically-modified-fruits-global-market-report
Optogenetics Global Market Report
https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
